ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,657,946 | -10.3% | 9,618,827 | +1.5% | 0.01% | 0.0% |
| Q2 2023 | $192,377,072 | +4.0% | 9,472,037 | -6.6% | 0.01% | 0.0% |
| Q1 2023 | $184,935,726 | -4.8% | 10,139,020 | +8.0% | 0.01% | -16.7% |
| Q4 2022 | $194,165,510 | -16.9% | 9,389,048 | +5.2% | 0.01% | -25.0% |
| Q3 2022 | $233,559,000 | +13.5% | 8,928,228 | +9.9% | 0.01% | +14.3% |
| Q2 2022 | $205,829,000 | +57.6% | 8,122,694 | +96.2% | 0.01% | +75.0% |
| Q1 2022 | $130,642,000 | -21.8% | 4,139,526 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $167,137,000 | +14.0% | 4,129,929 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $146,558,000 | +32.2% | 4,202,960 | +4.1% | 0.00% | +33.3% |
| Q2 2021 | $110,902,000 | +16.4% | 4,038,728 | +19.0% | 0.00% | 0.0% |
| Q1 2021 | $95,295,000 | +12.8% | 3,393,646 | +4.3% | 0.00% | 0.0% |
| Q4 2020 | $84,501,000 | +57.5% | 3,255,091 | +4.0% | 0.00% | +50.0% |
| Q3 2020 | $53,636,000 | -17.9% | 3,129,282 | +18.6% | 0.00% | -33.3% |
| Q2 2020 | $65,292,000 | +69.2% | 2,639,092 | -5.1% | 0.00% | +50.0% |
| Q1 2020 | $38,592,000 | +27.0% | 2,780,348 | -7.6% | 0.00% | +100.0% |
| Q4 2019 | $30,391,000 | +15.1% | 3,008,762 | +3.7% | 0.00% | 0.0% |
| Q3 2019 | $26,408,000 | +48.6% | 2,901,988 | +29.8% | 0.00% | 0.0% |
| Q2 2019 | $17,777,000 | -22.3% | 2,236,133 | +22.1% | 0.00% | 0.0% |
| Q1 2019 | $22,878,000 | +23.4% | 1,831,701 | +6.4% | 0.00% | 0.0% |
| Q4 2018 | $18,545,000 | +205.6% | 1,721,894 | +295.5% | 0.00% | – |
| Q3 2018 | $6,069,000 | +47.9% | 435,424 | +29.9% | 0.00% | – |
| Q2 2018 | $4,104,000 | +1254.5% | 335,270 | +1606.3% | 0.00% | – |
| Q1 2018 | $303,000 | – | 19,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |